
Spectral AI Receives FDA De Novo Clearance for DeepView System for Burn Indication
Spectral AI announced that the U.S. Food and Drug Administration (FDA) has granted De Novo classification for its DeepView System, authorizing the company to commence commercial distribution activities in the United States.








